Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCDNA3.1-V5-PTK2B Citations (2)

Originally described in: Exploiting ligand-protein conjugates to monitor ligand-receptor interactions.
Haruki H, Gonzalez MR, Johnsson K PLoS One. 2012;7(5):e37598. doi: 10.1371/journal.pone.0037598. Epub 2012 May 31.
PubMed Journal

Articles Citing pCDNA3.1-V5-PTK2B

Articles
SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase. Ounoughene Y, Fourgous E, Boublik Y, Saland E, Guiraud N, Recher C, Urbach S, Fort P, Sarry JE, Fesquet D, Roche S. Cancers (Basel). 2021 Dec 17;13(24). pii: cancers13246344. doi: 10.3390/cancers13246344. PubMed
Biliverdin reductase bridges focal adhesion kinase to Src to modulate synaptic signaling. Vasavda C, Semenza ER, Liew J, Kothari R, Dhindsa RS, Shanmukha S, Lin A, Tokhunts R, Ricco C, Snowman AM, Albacarys L, Pastore F, Ripoli C, Grassi C, Barone E, Kornberg MD, Dong X, Paul BD, Snyder SH. Sci Signal. 2022 May 10;15(733):eabh3066. doi: 10.1126/scisignal.abh3066. Epub 2022 May 10. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.